QC Manager: Biochemistry
Save this job and keep your search organized
Create a free account to save jobs, create alerts and return to this listing from your dashboard.
By continuing, you agree to our Terms & Privacy Policy.
QC Manager: Biochemistry
Location: Cape Town
Industry: Pharmaceutical Manufacturing
Reference: MVG/QCM
A leading pharmaceutical manufacturer is seeking an experienced QC Manager: Biochemistry to lead Quality Control Biochemistry operations supporting sterile manufacturing.
This role is responsible for ensuring compliant, efficient, and high-quality testing activities aligned to cGMP, regulatory requirements, and industry best practices.
Key Requirements:
- Bachelor's or Master's degree in Biochemistry, Biotechnology, Molecular Biology, Microbiology, or related scientific field.
- Minimum 6 years' experience within the pharmaceutical, vaccine, or biotech manufacturing industry.
- At least 3 years' management experience within a QC or laboratory environment.
- Strong knowledge of cGMP, GLP, SAHPRA, WHO, quality systems, and regulatory compliance.
- Experience managing analytical method validation, transfers, investigations, CAPAs, OOS/OOT, and laboratory operations.
- Experience supporting site start-up, commissioning, qualification, technology transfer, or new facility readiness activities will be highly advantageous.
- Non-Negotiable: Extensive experience in GMP Compliance
Key Responsibilities:
- Lead and develop the QC Biochemistry team.
- Oversee testing, validation, stability, and method lifecycle activities.
- Ensure audit readiness, data integrity (ALCOA+), and regulatory compliance.
- Drive continuous improvement, operational excellence, and laboratory capability enhancement.
- Support new product introductions, technology transfers, and cross-functional projects.
This opportunity is ideal for a commercially aware, solutions-driven leader who thrives in complex environments, embraces change, and can successfully lead teams through growth, transformation, and operational scale-up.
Closing date: 16 October 2026